Carmat, the designer and developer of a totally artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has appointed Thierry Dupoux as Senior Director of Quality Assurance.
Thierry Dupoux is a seasoned medical device professional with a strong and large expertise in quality assurance / regulatory affairs and R&D.
Engineering Graduate from Ecole Centrale de Lyon (France), he has worked most of his career for Life Sciences companies such as General Electric where he became Supply Chain Quality & Compliance Manager for the plant of Buc (France) in his last position.
In 2006, he joined Sorin Group, now named LivaNova, a world leader in Cardiac Surgery and Neuromodulation. In the past 12 years at LivaNova, he held several senior positions in quality assurance, regulatory affairs and R&D.
Prior to joining Carmat, he was VP of Quality Assurance at LivaNova where he led the integration of the quality systems following the merger between Sorin Group and Cyberonics.
Dupoux commented: "The device designed by Carmat is a true engineering challenge that has no equivalent today. I am excited to join Carmat to support the company in bringing this highly needed technology to the market as soon as possible. Advanced heart failure is one the most important issue that modern medicine has to face and Carmat is clearly one of the few solutions for the foreseeable future."
